BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30

• BioMidwest

  Loncar Investments Launches Cancer Immunotherapy Index

  April 7, 2015

   · 

  2 min read
• Drug Development

  Clovis Oncology Receives Breakthrough Therapy Designation For Rucaparib For Monotherapy Treatment Of Advanced Ovarian Cancer In Patients With BRCA-Mutated Tumors (Inclusive Of Both Germline And Somatic BRCA Mutations)

  April 7, 2015

   · 

  9 min read
• Resverlogix Corporation Receives Two Patents For RVX-208 In China

  April 7, 2015

   · 

  3 min read
• Pharm Country

  VisiVite Launches AREDS2 E-Free Blue Formula: Macular Support For Those On Anticoagulant Therapies

  April 7, 2015

   · 

  3 min read
• Biotech Beach

  Arena Pharmaceuticals, Inc. Receives Additional Patent For BELVIQ (lorcaserin HCl) From United States Patent And Trademark Office

  April 7, 2015

   · 

  10 min read
• BioMidwest

  SAFC Launches New EX-CELL Advanced Products For Scalable, Efficient Biopharmaceutical Manufacturing

  April 7, 2015

   · 

  3 min read
• Drug Development

  Ocular Therapeutix Reports Topline Clinical Data For Its Second Phase 3 Clinical Trial Evaluating OTX-DP For The Treatment Of Post-Surgical Ocular Inflammation And Pain

  April 7, 2015

   · 

  11 min read
• BioMidwest

  CeraPedics, Inc. Announces Closing Of Loan And Equity Financing

  April 7, 2015

   · 

  1 min read
• Drug Development

  Celldex’ Phase 2 EMERGE Study Of Glembatumumab Vedotin In Metastatic Breast Cancer Published In Journal Of Clinical Oncology

  April 7, 2015

   · 

  7 min read
• BioMidwest

  Venaxis, Inc. To Provide Business Update

  April 7, 2015

   · 

  3 min read